跳至主要内容
临床试验/NCT03396120
NCT03396120已完成不适用

The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease

Assiut University2 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2017年2月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
95
试验地点
2
主要终点
value of FVC/DLCO in predicting PAH in IPF

研究概览

简要总结

Pulmonary hypertension (PH) is a common disorder among patients with interstitial lung disease (ILD). The symptoms are usually nonspecific and overlooked. Thus, a noninvasive screening modality is recommended for early detection of PH because of its potentially significant impact on treatment strategy and clinical outcomes.

Objectives: To evaluate the usefulness of assessing forced vital capacity (FVC%), diffusion capacity of the lung for carbon monoxide (DLCO%), and FVC%/DLCO% ratio to predict pulmonary hypertension among patients with ILDs.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • This retrospective study included all patients diagnosed with interstitial lung disease (ILD) who were followed up by the chest department of a tertiary hospital between September 2016 and January 2017

排除标准

  • patients with occupational history
  • collagen vascular disease predisposing them to lung disorders
  • patients who could not undergo pulmonary function testing

结局指标

主要结局

value of FVC/DLCO in predicting PAH in IPF

时间窗: 6 months

To evaluate the usefulness of assessing forced vital capacity (FVC%), diffusion capacity of the lung for carbon monoxide (DLCO%), and FVC%/DLCO% ratio to predict pulmonary hypertension among patients with ILDs

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Aliae AR Mohamed Hussein

Professor of Pulmonology

Assiut University

研究点 (2)

Loading locations...

相似试验